Submit Your Article CMED MEACR meeting
Home Print this page Email this page Users Online: 623
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

A prospective randomized controlled trial to study the role of sulfasalazine in prevention of acute gastrointestinal toxicity associated with concurrent chemoradiation in carcinoma cervix

Pal Santanu, Adhikary Shyam Sundar, Bhattacharya Biswamit, Basu Joydeep, Ghosh Tanmoy, Patra Niladri Behari

Year : 2013| Volume: 2| Issue : 2 | Page no: 118-121

   This article has been cited by
 
1 Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers
Theresa A Lawrie,John T Green,Mark Beresford,Linda Wedlake,Sorrel Burden,Susan E Davidson,Simon Lal,Caroline C Henson,H. Jervoise N Andreyev
Cochrane Database of Systematic Reviews. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Pelvic Radiation and Normal Tissue Toxicity
Sarah Nicholas,Linda Chen,Amanda Choflet,Amanda Fader,Zachary Guss,Sarah Hazell,Daniel Y. Song,Phuoc T. Tran,Akila N. Viswanathan
Seminars in Radiation Oncology. 2017; 27(4): 358
[Pubmed]  [Google Scholar] [DOI]
3 N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Robert C. Miller,Daniel G. Petereit,Jeff A. Sloan,Heshan Liu,James A. Martenson,James D. Bearden,Ronald Sapiente,Grant R. Seeger,Rex B. Mowat,Ben Liem,Matthew J. Iott,Charles L. Loprinzi
International Journal of Radiation Oncology*Biology*Physics. 2016; 95(4): 1168
[Pubmed]  [Google Scholar] [DOI]
4 Prevention of pelvic radiation disease
Lorenzo Fuccio
World Journal of Gastrointestinal Pharmacology and Therapeutics. 2015; 6(1): 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article